This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

NeuroGlove PD Study Clinical

Sponsored by NeuroGlove LLC

About this trial

Last updated 10 months ago

Study ID

REG-1010

Status

Completed

Type

Interventional

Phase

Early Phase 1

Placebo

No

Accepting

18-75 Years
18 to 85 Years
All
All

Trial Timing

Ended a year ago

What is this trial about?

Safety and Feasibility of Peripheral Sensory Stimulation of the Hand in the Treatment of Parkinson's Disease

What are the participation requirements?

Yes

Inclusion Criteria

1. Able to and willing to provide informed consent. Legally authorized representatives (LARs) will not be allowed to consent on behalf of the subject.

2. Men and women ≥18 and <85 years of age.

3. Carry an active diagnosis of PD

4. Suffer from PD symptoms that impact subject's daily activities and quality of life

No

Exclusion Criteria

5. Physical limitations of the upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.)

6. Lacks the ability to comprehend or follow instructions, or for any reason, in the opinion of the investigator, would be unlikely or unable to comply with study protocol requirements.

7. Currently participating in another interventional clinical trial (observational clinical trial participation is allowed for study enrollment.)